The Digital Medicine Society (DiMe) teamed up with a slew of pharma giants and payers to launch a digital endpoints toolkit for stakeholders.
The open-access toolkit, which came from a partnership between DiMe, Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer and Savvy Co-op, gives payers a road map for including digital endpoints in reimbursement for new drugs. Dubbed the 3Ps toolkit...
